Ral Overactivation in Malignant Peripheral Nerve Sheath Tumors
Year: 2009
Type: article
Abstract: Ras leads an important signaling pathway that is deregulated in neurofibromatosis type 1 and malignant peripheral nerve sheath tumor (MPNST). In this study, we show that overactivation of Ras and many of its downstream effectors occurred in only a fraction of MPNST cell lines. RalA, however, was overactivated in all MPNST cells and tumor samples compared to nontransformed Schwann cells. Silencing Ral or inhibiting it with a dominant-negative Ral (Ral S28N) caused a significant reduction in proliferation, invasiveness, and in vivo tumorigenicity of MPNST cells. Silencing Ral also reduced the expression of epithelial mesenchymal transition markers. Expression of the NF1-GTPase-related domain (NF1-GRD) diminished the levels of Ral activation, implicating a role for neurofibromin in regulating RalA activation. NF1-GRD treatment caused a significant decrease in proliferation, invasiveness, and cell cycle progression, but cell death increased. We propose Ral overactivation as a novel cell signaling abnormality in MPNST that leads to important biological outcomes with translational ramifications.
Source: Molecular and Cellular Biology
DOI: 10.1128/mcb.01153-08
Institutions: University of Minnesota, University of Kansas, Mayo Clinic, Southern Illinois University Carbondale, SIU Medicine, Universität Hamburg, University Medical Center Hamburg-Eppendorf, Indiana University School of Medicine, Edward Hines, Jr. VA Hospital, Harvard University, Massachusetts General Hospital, The University of Texas Southwestern Medical Center
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: U.S. Department of Defense
OpenAlex ID: W2128434997
